$SNX

HUME RICHARD T sold $1.2M of SNX

HUME RICHARD T sold 5,000 shares of TD SYNNEX CORP (SNX) at an average of $242.97 ($237.93–$248.28, $1.21M total) across 10 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · HUME RICHARD T
Published Jul 7, 2026, 9:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 7, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$SNX
Neutral
medium confidence
Mentioned
$SNX
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$SNXNeutralLow
01

Why it matters

The disclosed fact is the director’s open-market sale size, price range, and post-sale holdings; it does not include any new operational or financial guidance from the company.

02

Market read

Traders may note the insider sale for positioning/sentiment, but there is no fundamental catalyst in the filing text.

03

What to watch

The article provides only the sale details; it does not state whether the director’s overall holdings changed materially beyond the post-transaction balance, nor does it include any concurrent company news.

Relevance 5/10Novelty 5/10Timing: Filed after-hours on 2026-07-07; sale executed on 2026-07-06.

Background

The article is an SEC Form 4 insider transaction disclosure for TD SYNNEX (SNX) by director Hume Richard T, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$SNXNeutralMedium confidence
Context

SEC Form 4 shows director Hume Richard T sold 5,000 SNX shares in an open-market transaction totaling about $1.21M under a 10b5-1 plan.

Expected impact

Likely limited immediate price impact; any effect is more sentiment/flow-related than fundamental.

Evidence & confidence

The filing is a routine insider sale coded as open-market and explicitly tied to a pre-arranged 10b5-1 plan, with no accompanying company-specific news (earnings, guidance, deals, or regulatory actions).

Market effects

None indicated; this is a single-company insider transaction with no sector-wide catalyst.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can be interpreted by some traders as confidence erosion, especially if paired with other negative signals (not present here).

Key entities

  • TD SYNNEX CORP

    Company whose shares were sold by a director under a 10b5-1 plan.

  • HUME RICHARD T

    Director who sold 5,000 shares of SNX across 10 trades on 2026-07-06.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SNXMed

TD SYNNEX stock: BlueStar deal follows a cash-flow reversal

TD SYNNEX agreed to buy BlueStar, expanding its tech distribution. The deal lacks a disclosed price and awaits approvals. TD SYNNEX's latest quarter showed $416.2M net income but a $916.7M operating cash outflow, raising cash-flow concerns. Shares fell 2.46% on Oct 7. BlueStar's addition could broaden offerings, but financial details are unclear.

$TDMed

TD SYNNEX Adding Specialty Technology Distributor BlueStar

TD SYNNEX agreed to acquire BlueStar, a specialty tech distributor, to expand its offerings. BlueStar focuses on tech like RFID and robotics. TD SYNNEX reported Q3 revenue of $21.6B, up 37.7% Y/Y, and forecasts Q4 revenue of $21.8B-$22.6B. The deal is subject to approvals.

$TDMed

TD SYNNEX to Acquire Specialty Technology Distributor BlueStar

TD SYNNEX agreed to acquire BlueStar, a specialty tech distributor. The deal expands TD SYNNEX's capabilities in AIDC, operational tech, and mobility. Financial terms were not disclosed. The transaction is subject to regulatory approvals. Both companies will operate independently until closing. BlueStar specializes in technologies like RFID and point-of-sale systems. TD SYNNEX plans to combine BlueStar's expertise with its global platform.

$SNXHigh

TD SYNNEX to acquire specialty distributor BlueStar

TD SYNNEX (NYSE:SNX) agreed to acquire BlueStar, a specialty tech distributor. The deal is pending regulatory approval. BlueStar specializes in AIDC and related technologies. Financial terms were not disclosed. Both companies will operate independently until the transaction closes. SNX is a global distributor supporting 150,000+ customers across 100+ countries.